Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | MITF | O75030 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15224501 | 0.89 | SLC2A1 (0.39) | CYP19A1PBRM1LMNASLC2A1 | |
| SCHEMBL15224529 | 0.88 | SLC2A1 (0.42) | CYP19A1PBRM1LMNAALDH1A1SLC2A1 | |
| SCHEMBL28271087 | 0.86 | SLC2A1 (0.44) | HTTLMNAALDH1A1SLC2A1 | |
| SCHEMBL15225006 | 0.86 | SLC2A1 (0.44) | HTTLMNAALDH1A1SLC2A1 | |
| SCHEMBL15226202 | 0.85 | GPR88 (0.33) | — | |
| SCHEMBL5072879 | 0.85 | CYP17A1 (0.45) | CYP19A1PBRM1CYP17A1NPSR1ALDH1A1 | |
| SCHEMBL15224764 | 0.84 | CYP19A1 (0.35) | CYP19A1PBRM1MITFHTTCNR1 | |
| SCHEMBL15224464 | 0.83 | MEN1 (0.42) | PBRM1HTTLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL15225008 | 0.83 | FFAR1 (0.38) | CYP19A1PBRM1CYP17A1MITFHTT | |
| SCHEMBL15224837 | 0.81 | RARB (0.34) | CYP19A1PBRM1MITFHTTCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3438146-B1 | CYANIC ACID ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, CURED ARTICLE, PREPREG, SEALING MATERIAL, FIBER-REINFORCED COMPOSITE MATERIAL, ADHESIVE AGENT, METAL FOIL-CLAD LAMINATE PLATE, RESIN SHEET, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL CO (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12534617-B2 | Resin composition, cured product, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-27 | — | — | US | disclosed |
| US-12486371-B2 | Thermally curable resin composition, cured object, resin sheet, prepreg, metal-clad laminate, multilayered printed wiring board, sealing material, fiber-reinforced composite material, adhesive, and semiconductor device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-12-02 | — | — | US | disclosed |
| EP-3805293-B1 | RESIN COMPOSITION, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN SHEET, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL CO (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-4610285-A1 | RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-09-03 | — | — | EP | disclosed |
| EP-4610287-A1 | RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-12312323-B2 | Compound, method for producing same, resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-27 | — | — | US | disclosed |
| US-20250109222-A1 | CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-04-03 | — | — | US | disclosed |
| EP-4438655-A1 | CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-10-02 | — | — | EP | disclosed |
| US-12091542-B2 | Resin composition, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-09-17 | — | — | US | disclosed |
| EP-2733159-A1 | CURABLE RESIN COMPOSITION AND PROCESS FOR PRODUCING CURED PRODUCTS USING SAME | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-05-21 | — | — | EP | disclosed |
| EP-2671904-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF | Mitsubishi Gas Chemical Company, Inc. (JP) | 2013-12-11 | — | — | EP | disclosed |
| US-20130288063-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-20130281640-A1 | CYANATE ESTER COMPOUND, CURABLE RESIN COMPOSITION CONTAINING CYANATE ESTER COMPOUND, AND CURED PRODUCT THEREOF | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-10-24 | — | — | US | disclosed |
| EP-2634205-A1 | CYANATE ESTER COMPOUND, CURABLE RESIN COMPOSITION CONTAINING CYANATE ESTER COMPOUND, AND CURED PRODUCT THEREOF | Mitsubishi Gas Chemical Company, Inc. (JP) | 2013-09-04 | — | — | EP | disclosed |
| EP-2597114-A1 | Organic-inorganic composite materials containing triazine rings and electrical devices using the same | Hitachi Ltd. (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-20130131248-A1 | ORGANIC-INORGANIC COMPOSITE MATERIALS CONTAINING TRIAZINE RINGS AND ELECTRICAL DEVICES USING THE SAME | HITACHI, LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-7767739-B2 | Cyanato group-containing cyclic phosphazene compound and method for producing the same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-6225492-B1 | CONTACTING CYANATE CRUDE PRODUCT SOLUTION COMPRISING CYANATE, UNSUBSTITUTED PHENOL AND NON-ALCOHOLIC SOLVENT WITH POOR SOLVENT CONTAINING ALCOHOL AND WATER TO CRYSTALLIZE OR PRECIPITATE SAID CYANATE | SUMITOMO CHEMICAL CO., LTD. (JP) | 2001-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | CENPE, CPNE4, MCM3 | CYP19A1 3807/4885PBRM1 1442/4885CYP17A1 3487/4885 |
| US-20250109222-A1 | CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE | ZYX, MUS81, H1-0 | CYP19A1 4023/4885PBRM1 1480/4885CYP17A1 4309/4885 |
| US-12534617-B2 | Resin composition, cured product, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board | CHRM1, MRPL37, MRPL38 | CYP19A1 3593/4885PBRM1 457/4885CYP17A1 4549/4885 |
| US-12312323-B2 | Compound, method for producing same, resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | ASH2L, RER1, SEM1 | CYP19A1 2353/4885PBRM1 445/4885CYP17A1 2498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.